Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: M. Ramle who wrote (1300)	10/14/1998 2:54:00 PM
From: David Howe	Read Replies (1) of 10280

The buyers are starting to come back. Now back above 59. I am extremely bullish on the long term outlook for SEPR. There is one thing that keeps me from betting the farm on this one investment. My concern is that one of the original patent holders will sue SEPR. Lilly could take that route. If SEPR decides to develop and market their improved version of Prozac on their own, Lilly could claim patent infringement. Lilly would be wrong and they would probably lose, however, it would hurt SEPR's stock price and make it more difficult for them to reach agreements with the other major pharmas. This risk is the only risk that I see for SEPR. It is a risk that I have considered and view as only a slight possibility. SEPR has reached several outstanding agreements with J&J and others. SEPR is in an excellent position. If someone could convince me that without a doubt, SEPR is not in danger of legal battles (in addition to the Alegra situation) I would triple my position in SEPR. Someone please convince me of this before we are at 90! Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next